News

AbstractPatients with sickle cell disease (SCD) experience multisystem complications, with sickle cell nephropathy being a major contributor to chronic kidney…

The RUBY trial demonstrates that disrupting the BCL11A binding site in the γ-globin promoters can normalize hemoglobin in severe sickle cell disease.Background: The…

The BEACON clinical trial showed therapy's lasting benefits in 31 patientsBeam Therapeutics plans to ask the U.S. Food and Drug Administration (FDA) to approve…

The Focus on Sickle Cell (FoSCel) Foundation has announced that the Great Hall of the Kwame Nkrumah University of Science and Technology (KNUST) in Kumasi will host…

A major step forward for sickle cell care in Georgia is now awaiting the governor's signature.On the final day of the 2026 legislative session, lawmakers passed…

Anaemia is a common condition characterised by a lower-than-normal number of red blood cells or haemoglobin in the blood. Anaemia is a major health concern in India…

Background: Sickle cell disease is a hereditary hemoglobinopathy commonly seen in sub-Saharan Africa, India, and the Middle East. It is caused by a mutation in the…

Ngoe Samuel BakiaDepartment of Pharmaceutical Sciences, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Cameroon.Chetcha Bernard…

A group of advocates, caregivers and people with sickle cell anemia walk into the Georgia Capitol to share their stories about sickle cell in March 2026.

On December 17, 2024, a quiet but seismic shift happened in a hospital on Long Island. A 21-year-old Black man named Sebastien Beauzile, who had spent most of his…